Latest / The Full Ratchet (TFR): Venture Capital and Startup Investing Demystified
282. The Future of Public Health, VC Differentiation within Life Sciences, and Preventing the Next Pandemic (Glenn Rockman)
Glenn Rockman of Adjuvant Capital joins Nick to discuss The Future of Public Health, VC Differentiation within Life Sciences, and Preventing the Next Pandemic. In this episode, we cover:
Walk us through your background and path to VC.
What's the thesis at Adjuvant?
When taking on strategic LPs, especially those that are very high profile, and have their own mandates and their own agendas, do they inform you where you deploy capital, or is Adjuvant completely independent and financially motivated?
Is there a standard stage within the clinical or development process that you enter in? Standard…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.